IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes.
about
Mitochondrial dysfunction in heart failureEffects of endotoxaemia on protein metabolism in rat fast-twitch skeletal muscle and myocardium.Mitochondrial integrity: preservation through Akt/Pim-1 kinase signaling in the cardiomyocyteIL-6 in diabetes and cardiovascular complications.HIF-1α signaling activation by post-ischemia treatment with astragaloside IV attenuates myocardial ischemia-reperfusion injury.The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity.Overexpression of S100A7 protects LPS-induced mitochondrial dysfunction and stimulates IL-6 and IL-8 in HaCaT cells.Mitochondrial Ca²⁺ and membrane potential, an alternative pathway for Interleukin 6 to regulate CD4 cell effector functionInhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion.Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer.The varying faces of IL-6: From cardiac protection to cardiac failure.Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways.Predicting the outcomes for out-of-hospital cardiac arrest patients using multiple biomarkers and suspension microarray assaysA novel mechanism by which SDF-1β protects cardiac cells from palmitate-induced endoplasmic reticulum stress and apoptosis via CXCR7 and AMPK/p38 MAPK-mediated interleukin-6 generation.IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart.Myocardial protection by nitriteJAK redux: a second look at the regulation and role of JAKs in the heart.Protein kinase Cε-calcineurin cosignaling downstream of toll-like receptor 4 downregulates fibrosis and induces wound healing gene expression in cardiac myofibroblasts.Fibrosis and heart failure.Trans-system mechanisms against ischemic myocardial injury.Engineering mammalian cells to seek senescence associated secretory phenotypes.Improving stem cell therapy in cardiovascular diseases: the potential role of microRNA.IL-6 Activates PI3K and PKCζ Signaling and Determines Cardiac Differentiation in Rat Embryonic H9c2 Cells.Role of Inflammation in Heart Failure.p42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation.alpha1-Adrenergic receptor stimulates interleukin-6 expression and secretion through both mRNA stability and transcriptional regulation: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB.Adiponectin induces interleukin-6 production and its underlying mechanism in adult rat cardiac fibroblasts.Interleukin-6 Mediates Post-Infarct Repair by Cardiac Explant-Derived Stem Cells.Immunity, Inflammation, and Oxidative Stress in Heart Failure: Emerging Molecular Targets.Hypoxic preconditioning induces elevated expression of stanniocalcin-1 in the heart.Interleukin-6 mediates exercise preconditioning against myocardial ischemia reperfusion injury.Interleukin-6 contributes to the paracrine effects of cardiospheres cultured from human, murine and rat hearts.Interleukin-27, a novel cytokine induced by ischemia-reperfusion injury in rat hearts, mediates cardioprotective effects via the gp130/STAT3 pathway.Interleukin 6 protects H(2)O(2)-induced cardiomyocytes injury through upregulation of prohibitin via STAT3 phosphorylation.
P2860
Q26851293-AECB2E68-8861-47EA-8DA6-878A8FC72CA5Q33504197-A2120143-0870-41CD-9ADC-54A9DC24D641Q33791025-F253F58B-B061-46BF-9C6F-512C62B95A9BQ34025142-9BE3496F-8AC3-4915-B21B-EA3A0B9C816CQ34215980-87E7BBE1-DA1E-4AFD-A3BF-63334ABF7763Q34534895-6D7115C3-CC46-47EB-869A-192B7331C12AQ35132156-29B682EA-20D6-40B1-A214-CBC2407BD9EBQ35662424-BB334DF6-5D53-41A0-8172-EA99E67FE71FQ36217826-D5E781C2-906C-4A54-8801-0BB8257B3AACQ36229684-49196955-7E93-4A7D-AEF8-D0C08EB0A8BDQ36368339-0CD36B4F-0151-42F8-B4BB-759D4EF37846Q36681664-8C92F5D8-85EC-43BF-A112-CCECCD427D53Q36964921-0603D547-415D-4187-8BD2-77CD3D847CE6Q37014884-E3A21DA9-F3B4-4C25-9F3D-DBCF2A776C37Q37200229-E96B491A-1D74-4383-9AAE-CB6D70648DFEQ37240946-1C1F872C-D40E-4C6C-8BC7-F7E67F660A9FQ37430884-3F589A24-A70D-4A2C-95D7-22B6486BFA29Q37546836-91014B43-DAB0-4D99-8559-EDA40FD714BFQ38057701-8299463C-DC6D-4928-B4A4-7231C2AC9003Q38318626-5FF71ADA-3F10-450F-8810-950591854493Q38654411-FDD9B454-4B9E-4EEB-9BD9-2548A7565B2AQ38840533-2205A669-A90D-43C9-9120-94EFF2156F51Q38849864-E7032681-21D5-4D3F-AC0C-497C30FF436AQ39255848-FBAE2A8C-8837-47D7-9AF4-3D212EF3A622Q39885290-B5D1A595-5D56-4F53-9ED7-BC198C64C8A2Q43106563-BC2D80ED-5CE6-4A50-B206-BF3335F6FB00Q44653158-0C049B1D-D857-4A21-AA23-AE18DD2B2769Q47108276-22BF1E81-0398-438E-95BA-9510252AC95BQ47756011-E0251EE4-D75D-4F97-9D9F-1CFF8F592A8CQ48134076-E03881DB-3ABC-42E5-A759-8AA178F76FF1Q53562942-09466782-08E8-409D-8064-C90459594FBDQ53599953-1A9873D8-BEF6-48D7-BCE3-45F9B148D9B2Q54168695-1FF4C384-1620-4E70-80A3-0E62A5561521Q54522449-9A8E64CB-2FD2-4611-883E-FA5A146D64D2
P2860
IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
IL-6 induces PI 3-kinase and n ...... al function in cardiomyocytes.
@en
IL-6 induces PI 3-kinase and n ...... al function in cardiomyocytes.
@nl
type
label
IL-6 induces PI 3-kinase and n ...... al function in cardiomyocytes.
@en
IL-6 induces PI 3-kinase and n ...... al function in cardiomyocytes.
@nl
prefLabel
IL-6 induces PI 3-kinase and n ...... al function in cardiomyocytes.
@en
IL-6 induces PI 3-kinase and n ...... al function in cardiomyocytes.
@nl
P2093
P1476
IL-6 induces PI 3-kinase and n ...... al function in cardiomyocytes.
@en
P2093
David S Latchman
Mart H Mojet
Nicola Smart
Richard J Heads
P304
P356
10.1016/J.CARDIORES.2005.08.017
P577
2005-10-10T00:00:00Z